Company intelligence / Profile preview

Athena Diagnostics

Worcester, Massachusetts, United Statesathenadiagnostics.com ↗

Ownership: Private
Employees: ~300
Development stage: Other

Overview

Athena Diagnostics provides over 400 advanced diagnostic tests focused on neurological, neuromuscular, endocrine and renal diseases. Their portfolio includes genetic sequencing panels and immunodiagnostics that aid in diagnosis or confirmation of complex medical conditions such as Alzheimer's disease and muscular dystrophies. The company has been recognized as an innovator in neurogenetic testing since its founding in the late '80s.\nNo clinical trial results apply since this is a diagnostics provider.

Therapeutic areas: EndocrinologyNeurologyNephrology
Modalities: Diagnostic testGenetic testingMolecular diagnosticsImmunodiagnostic tests
Industry: Molecular Diagnostics

Partnerships

Previously partnered with Nanogen on molecular markers/platforms pre-acquisition by Quest

Beyond the preview

Go deeper on Athena Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Athena Diagnostics.